Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
SlideShare a Scribd company logo

Pharmaceutical Sales & Marketing in India (PPT) by Prashanth Kumar & Team

•
•
R
roshansingh0525

Pharmaceutical Sales & Marketing in India (PPT) in subject of Pharma Marketing Management for Bachelor's in Pharmacy by Prashanth Kumar and Team.

Related slideshows

Role of marketing in healthcare industry
Role of marketing in healthcare industryRole of marketing in healthcare industry
Role of marketing in healthcare industry
 
Shout it from the Rooftops
Shout it from the RooftopsShout it from the Rooftops
Shout it from the Rooftops
 
Value Innovation To Pharma - What Changes To Busisness, Zurich 2008
Value Innovation To Pharma - What Changes To Busisness, Zurich 2008Value Innovation To Pharma - What Changes To Busisness, Zurich 2008
Value Innovation To Pharma - What Changes To Busisness, Zurich 2008
 
1 of 26
Download to read offline
“PHARMACEUTICAL SALES AND MARKETING IN INDIA” BY A dissertation submitted to the Rajiv Gandhi University of Health Sciences, Karnataka, Bangaluru in partial fulfillment of the requirements for the Degree of BACHELOR OF PHARMACY IN PHARMACEUTICAL MARKETING Under the guidance of Mr SRIKANT PATIL – M.Pharm (Ph.D.) Department of Pharmaceutics K.R.E.S’s Karnataka College of Pharmacy Bidar – 585403 2021 SWAMI POOJA RAJKUMAR SONAL N PATEL PRASHANTH KUMAR MAYURI PRABHURAO PATIL YUVARAJ AMRUTH
ABSTRACT The abstract provides a succinct overview of the pharmaceutical sales and marketing landscape in India. It highlights the industry's significance in the Indian economy, focusing on regulatory dynamics, market trends, and ethical considerations. The review explores diverse sales and marketing strategies, assessing their impact on the sector's growth. Challenges such as patent issues and counterfeit drugs are discussed alongside opportunities for market expansion. The abstract concludes with insights into the future outlook, anticipating potential regulatory changes and the integration of emerging technologies. This review aims to offer a comprehensive understanding of the current state and future prospects of pharmaceutical sales and marketing in India.
Keywords  Pharmaceutical Industry India  Sales Strategies  Marketing Strategies  Regulatory Landscape  Market Dynamics  Emerging Technologies  Generic Competition  Regulatory Compliance  Market Trends  Distribution Channels
INDEX SR NO. PARTICULARS 1 INTRODUCTION 2 IMPORTANCE OF THE PHARMACEUTICAL SECTOR IN THE INDIAN ECONOMY. 3 REGULATORY LANDSCAPE 4 SALES STRATEGIES 5 MARKETING STRATEGIES 6 CHALLENGES AND OPPORTUNITIES 7 ETHICAL CONSIDERATIONS 8 CONCLUSION
Economic Significance of the Indian Pharmaceutical Industry: Contribution to GDP: The pharmaceutical sector is a significant contributor to India's Gross Domestic Product (GDP), reflecting its economic importance. Job Creation: It is a major source of employment, spanning various roles from R&D to manufacturing and distribution. Technological Advancement: The industry is at the forefront of technological innovation, contributing to the nation's progress. Global Exports: As a key exporter, the pharmaceutical industry enhances India's global economic standing. Generic Drug Production: India is known for its substantial production of generic drugs, which has global healthcare implications. INTRODUCTION
2. Global Positioning: • Affordable Healthcare: The industry's focus on generic drugs ensures affordable healthcare options both domestically and internationally. • Major Supplier: India's role as a vital supplier of medicines worldwide underscores its global positioning. 3. Sales and Marketing as Growth Drivers: • Competitive Nature: The competitive landscape necessitates robust sales and marketing strategies. • Market Share Enhancement: Effective promotion and strategic marketing are essential for increasing market share. • Regulatory Navigation: Companies must adeptly navigate regulatory complexities to sustain growth.
IMPORTANCE OF THE PHARMACEUTICAL SECTOR IN THE INDIAN ECONOMY • Industrial Output: The pharmaceutical sector accounts for a substantial share of India's industrial output. • Research and Innovation: Emphasis on R&D positions India as a leader in pharmaceutical innovation. • Public Health: Access to quality medicines is crucial for public health initiatives and the well-being of the Indian population.
REGULATORY LANDSCAPE • Governing Bodies: The CDSCO and the Ministry of Health oversee the pharmaceutical industry, ensuring drug safety and efficacy. • Regulatory Framework: The framework balances innovation, public health protection, and ethical standards. • Stringent Requirements: Companies face stringent regulatory requirements, impacting product approvals. • Global Standards: Compliance with evolving global standards is challenging but necessary for international competitiveness. • Approval Timelines: Prolonged approval processes can delay market entry, affecting competitive positioning.
Sales strategies in the Indian pharmaceutical industry encompass a multifaceted approach. Companies employ direct sales and distribution channels, balancing the advantages of control with the efficiencies of broader market reach. With a focus on the unique characteristics of the Indian market, sales forces emphasize personalized interactions with healthcare professionals. Innovative models like e-detailing and tele-detailing leverage technology for efficient engagement. The industry places a premium on sales force effectiveness, continuous training programs, and performance metrics. A nuanced understanding of market trends, coupled with the integration of emerging technologies, guides pharmaceutical companies in developing effective and adaptive sales strategies. SALES STRATEGIES
1.Direct Sales and Distribution Channels: • Companies employ direct sales teams to engage with healthcare professionals (HCPs) directly. • Distribution channels include wholesalers, retailers, and stockists for efficient product distribution. 2. Technology Adoption: • Leveraging technology for efficient sales processes. • Digital tools, CRM systems, and mobile apps enhance interactions with HCPs. 3. Personalized Interactions: • Building strong relationships with doctors, pharmacists, and hospitals. • Customizing communication based on individual preferences and needs.
4. KOL Engagement: • Key Opinion Leaders (KOLs) play a crucial role in influencing other HCPs. • Collaborating with KOLs for product endorsements and education. 5. CME Programs and Medical Conferences: • Continuing Medical Education (CME) programs provide HCPs with updated knowledge. • Participation in medical conferences for networking and brand visibility. 6. Samples and Promotional Materials: • Providing product samples to HCPs for trial. • High-quality promotional materials (brochures, visual aids) enhance brand recall.
7. Incentives and Rewards: • Offering incentives to HCPs for meeting sales targets. • Rewards, travel opportunities, and recognition motivate sales representatives. 8. Digital Marketing: • Utilizing social media, email campaigns, and webinars. • Targeted online advertising to reach HCPs and patients. 9. Patient Education: • Educating patients about medications and treatment options. • Empowering patients to make informed decisions. 10. Compliance with Regulations: • Adhering to ethical guidelines and regulatory requirements. • Transparency in interactions with HCPs.
MARKETING STRATEGIES 1.Traditional Marketing: • Print Advertising: Traditional methods like print ads in medical journals and magazines remain integral. They provide detailed product information and research findings. • Conferences and Events: Face-to-face interactions at conferences allow companies to showcase products and build relationships with healthcare professionals. • Direct Mail: Targeted mail campaigns continue to be effective for reaching physicians and other stakeholders. 2. Digital Marketing: • Online Platforms: Leveraging websites, social media, and targeted digital campaigns to engage healthcare professionals and consumers. • Webinars: Educational webinars disseminate clinical trial updates and interactive product information.
3. Branding Strategies: • Strong Brand Identity: Establishing trust among healthcare professionals and consumers by emphasizing core values and a positive reputation. • Product Differentiation: Highlighting unique selling propositions, therapeutic benefits, and technological innovations. 4. Promotional Activities: • Direct-to-Physician Marketing: Pharmaceutical representatives engage with physicians to provide product information. • Awareness Campaigns: Initiatives educate healthcare professionals and create awareness among consumers. • Driving Product Adoption: Strategies to
5. Patient-Centric Marketing Approaches: • Empowering Patients: The shift towards patient-centric marketing recognizes patients as active participants in their healthcare decisions. • Tailored Information and Education: ■ Companies create and disseminate tailored information and educational content. ■ Channels include online platforms, patient forums, and informational materials. ■ Example: Materials explaining diabetes medication adherence, dietary guidelines, and potential side effects. • Digital Tools and Apps: ■ Leverage digital tools (e.g., medication reminder apps, symptom trackers) to engage patients actively. ■ Foster a direct line of communication between patients and pharmaceutical companies. • Example: Sun Pharma's 'RespiTrack': ■ Designed for respiratory patients, 'RespiTrack' provides information, resources, and tools. ■ Includes educational content,
6.Challenges and Considerations: • Regulatory Compliance: Stringent regulations govern promotional practices to ensure transparency, accuracy, and ethical engagements with healthcare professionals. • Balancing Promotion and Compliance: Successfully branding pharmaceutical products requires navigating the regulatory landscape while adhering to innovative and targeted strategies. • Positive Relationships: Companies must establish positive relationships with healthcare professionals and ensure effective communication with consumers. 7. Effectiveness: • Patient-centric marketing: ■ Builds trust. ■ Enhances brand loyalty. ■ Improves patient adherence.
1.Patent Issues and Generic Competition: • Patent Challenges: Innovator companies face challenges when patents expire, allowing generic manufacturers to produce affordable alternatives . • Generic Market: India's pharmaceutical market is characterized by a strong presence of generic drugs, which provide cost-effective options and challenge innovators to maintain their market share. • Impact on Sales: Patent expirations can lead to revenue erosion for innovator companies, necessitating strategic responses such as lifecycle management and innovative marketing strategies CHALLENGE AND OPPORTUNITIES
• Public Health Risks: Counterfeit drugs pose serious health risks and undermine patient safety, often containing harmful or ineffective ingredients . • Regulatory Challenges: The vast and complex pharmaceutical market in India presents challenges in curbing counterfeit drug production and distribution . • Industry Reputation: The prevalence ofcounterfeit drugs can damage the reputation of the pharmaceutical industry and erode trust among stakeholders . • Economic Impact: Counterfeit drugs impact the financial sustainability of pharmaceutical companies by competing with genuine products. • Supply Chain Vulnerability: The intricate supply chain in India is vulnerable to infiltration by counterfeit drugs, highlighting the need for stringent control measures Counterfeit Drugs:
Pharmaceutical Sales & Marketing in India (PPT) by Prashanth Kumar & Team
ETHICAL CONSIDERATIONS 1.Clinical Trials and Research: • Informed Consent: Participants must be fully informed about the trial and consent to participate. • Participant Confidentiality: Protecting the privacy and personal information of participants. • Safety and Well-being: Ensuring the safety and well-being of trial subjects is paramount. • Ethical Review Boards: These boards oversee and approve research protocols to maintain the integrity of clinical
2.Marketing and Promotion: • Accurate Information: Companies must provide accurate and balanced information about their products. • Avoiding Misleading Claims: It's important to avoid making misleading claims about medications. • Transparency: Transparency in promotional materials and interactions with healthcare professionals is vital. 3.Access to Medicines: • Affordability: Companies must consider the affordability of medications, especially life-saving ones. • Balancing Profitability: There needs to be a balance between profitability and the societal impact of medications.
4.Compliance with Regulations: • Adherence to Laws: Companies must comply with laws and regulations governing drug development, manufacturing, marketing, and distribution. • Regulatory Bodies: In India, for example, the CDSCO sets regulations that companies must follow. 5.Corporate Social Responsibility (CSR): • Positive Contributions: Companies engage in CSR initiatives to contribute positively to communities. • Beyond Profit-making: Ethical corporate behavior involves commitments to social causes and public health challenges.
Pharmaceutical Sales & Marketing in India (PPT) by Prashanth Kumar & Team
Dynamic Landscape: • The pharmaceutical sector contributes significantly to the economy. • It operates within a complex regulatory environment that requires ethical vigilance. Market Dynamics: • The market is characterized by the presence of significant players. • Digital transformation and patient- centricity are key trends. • Counterfeit drugs and generic competition present ongoing challenges. CONCLUSION
Strategic Balance: • There is a need to balance business objectives with ethical practices. • The industry must navigate between profitability and ethical responsibilities. Future Prospects: • Growth opportunities exist in the generic drug market and digital health solutions. • Emerging technologies are set to redefine sales and marketing strategies. • Innovation and regulatory agility will be pivotal for future success.
THANK YOU PRESENTED BY SWAMI POOJA RAJKUMAR PRASHANTH KUMAR SONAL N PATEL MAYURI PRABHURAO PATIL YUVARAJ AMRUTH

More Related Content

Pharmaceutical Sales & Marketing in India (PPT) by Prashanth Kumar & Team

  • 1. “PHARMACEUTICAL SALES AND MARKETING IN INDIA” BY A dissertation submitted to the Rajiv Gandhi University of Health Sciences, Karnataka, Bangaluru in partial fulfillment of the requirements for the Degree of BACHELOR OF PHARMACY IN PHARMACEUTICAL MARKETING Under the guidance of Mr SRIKANT PATIL – M.Pharm (Ph.D.) Department of Pharmaceutics K.R.E.S’s Karnataka College of Pharmacy Bidar – 585403 2021 SWAMI POOJA RAJKUMAR SONAL N PATEL PRASHANTH KUMAR MAYURI PRABHURAO PATIL YUVARAJ AMRUTH
  • 2. ABSTRACT The abstract provides a succinct overview of the pharmaceutical sales and marketing landscape in India. It highlights the industry's significance in the Indian economy, focusing on regulatory dynamics, market trends, and ethical considerations. The review explores diverse sales and marketing strategies, assessing their impact on the sector's growth. Challenges such as patent issues and counterfeit drugs are discussed alongside opportunities for market expansion. The abstract concludes with insights into the future outlook, anticipating potential regulatory changes and the integration of emerging technologies. This review aims to offer a comprehensive understanding of the current state and future prospects of pharmaceutical sales and marketing in India.
  • 3. Keywords  Pharmaceutical Industry India  Sales Strategies  Marketing Strategies  Regulatory Landscape  Market Dynamics  Emerging Technologies  Generic Competition  Regulatory Compliance  Market Trends  Distribution Channels
  • 4. INDEX SR NO. PARTICULARS 1 INTRODUCTION 2 IMPORTANCE OF THE PHARMACEUTICAL SECTOR IN THE INDIAN ECONOMY. 3 REGULATORY LANDSCAPE 4 SALES STRATEGIES 5 MARKETING STRATEGIES 6 CHALLENGES AND OPPORTUNITIES 7 ETHICAL CONSIDERATIONS 8 CONCLUSION
  • 5. Economic Significance of the Indian Pharmaceutical Industry: Contribution to GDP: The pharmaceutical sector is a significant contributor to India's Gross Domestic Product (GDP), reflecting its economic importance. Job Creation: It is a major source of employment, spanning various roles from R&D to manufacturing and distribution. Technological Advancement: The industry is at the forefront of technological innovation, contributing to the nation's progress. Global Exports: As a key exporter, the pharmaceutical industry enhances India's global economic standing. Generic Drug Production: India is known for its substantial production of generic drugs, which has global healthcare implications. INTRODUCTION
  • 6. 2. Global Positioning: • Affordable Healthcare: The industry's focus on generic drugs ensures affordable healthcare options both domestically and internationally. • Major Supplier: India's role as a vital supplier of medicines worldwide underscores its global positioning. 3. Sales and Marketing as Growth Drivers: • Competitive Nature: The competitive landscape necessitates robust sales and marketing strategies. • Market Share Enhancement: Effective promotion and strategic marketing are essential for increasing market share. • Regulatory Navigation: Companies must adeptly navigate regulatory complexities to sustain growth.
  • 7. IMPORTANCE OF THE PHARMACEUTICAL SECTOR IN THE INDIAN ECONOMY • Industrial Output: The pharmaceutical sector accounts for a substantial share of India's industrial output. • Research and Innovation: Emphasis on R&D positions India as a leader in pharmaceutical innovation. • Public Health: Access to quality medicines is crucial for public health initiatives and the well-being of the Indian population.
  • 8. REGULATORY LANDSCAPE • Governing Bodies: The CDSCO and the Ministry of Health oversee the pharmaceutical industry, ensuring drug safety and efficacy. • Regulatory Framework: The framework balances innovation, public health protection, and ethical standards. • Stringent Requirements: Companies face stringent regulatory requirements, impacting product approvals. • Global Standards: Compliance with evolving global standards is challenging but necessary for international competitiveness. • Approval Timelines: Prolonged approval processes can delay market entry, affecting competitive positioning.
  • 9. Sales strategies in the Indian pharmaceutical industry encompass a multifaceted approach. Companies employ direct sales and distribution channels, balancing the advantages of control with the efficiencies of broader market reach. With a focus on the unique characteristics of the Indian market, sales forces emphasize personalized interactions with healthcare professionals. Innovative models like e-detailing and tele-detailing leverage technology for efficient engagement. The industry places a premium on sales force effectiveness, continuous training programs, and performance metrics. A nuanced understanding of market trends, coupled with the integration of emerging technologies, guides pharmaceutical companies in developing effective and adaptive sales strategies. SALES STRATEGIES
  • 10. 1.Direct Sales and Distribution Channels: • Companies employ direct sales teams to engage with healthcare professionals (HCPs) directly. • Distribution channels include wholesalers, retailers, and stockists for efficient product distribution. 2. Technology Adoption: • Leveraging technology for efficient sales processes. • Digital tools, CRM systems, and mobile apps enhance interactions with HCPs. 3. Personalized Interactions: • Building strong relationships with doctors, pharmacists, and hospitals. • Customizing communication based on individual preferences and needs.
  • 11. 4. KOL Engagement: • Key Opinion Leaders (KOLs) play a crucial role in influencing other HCPs. • Collaborating with KOLs for product endorsements and education. 5. CME Programs and Medical Conferences: • Continuing Medical Education (CME) programs provide HCPs with updated knowledge. • Participation in medical conferences for networking and brand visibility. 6. Samples and Promotional Materials: • Providing product samples to HCPs for trial. • High-quality promotional materials (brochures, visual aids) enhance brand recall.
  • 12. 7. Incentives and Rewards: • Offering incentives to HCPs for meeting sales targets. • Rewards, travel opportunities, and recognition motivate sales representatives. 8. Digital Marketing: • Utilizing social media, email campaigns, and webinars. • Targeted online advertising to reach HCPs and patients. 9. Patient Education: • Educating patients about medications and treatment options. • Empowering patients to make informed decisions. 10. Compliance with Regulations: • Adhering to ethical guidelines and regulatory requirements. • Transparency in interactions with HCPs.
  • 13. MARKETING STRATEGIES 1.Traditional Marketing: • Print Advertising: Traditional methods like print ads in medical journals and magazines remain integral. They provide detailed product information and research findings. • Conferences and Events: Face-to-face interactions at conferences allow companies to showcase products and build relationships with healthcare professionals. • Direct Mail: Targeted mail campaigns continue to be effective for reaching physicians and other stakeholders. 2. Digital Marketing: • Online Platforms: Leveraging websites, social media, and targeted digital campaigns to engage healthcare professionals and consumers. • Webinars: Educational webinars disseminate clinical trial updates and interactive product information.
  • 14. 3. Branding Strategies: • Strong Brand Identity: Establishing trust among healthcare professionals and consumers by emphasizing core values and a positive reputation. • Product Differentiation: Highlighting unique selling propositions, therapeutic benefits, and technological innovations. 4. Promotional Activities: • Direct-to-Physician Marketing: Pharmaceutical representatives engage with physicians to provide product information. • Awareness Campaigns: Initiatives educate healthcare professionals and create awareness among consumers. • Driving Product Adoption: Strategies to
  • 15. 5. Patient-Centric Marketing Approaches: • Empowering Patients: The shift towards patient-centric marketing recognizes patients as active participants in their healthcare decisions. • Tailored Information and Education: ■ Companies create and disseminate tailored information and educational content. ■ Channels include online platforms, patient forums, and informational materials. ■ Example: Materials explaining diabetes medication adherence, dietary guidelines, and potential side effects. • Digital Tools and Apps: ■ Leverage digital tools (e.g., medication reminder apps, symptom trackers) to engage patients actively. ■ Foster a direct line of communication between patients and pharmaceutical companies. • Example: Sun Pharma's 'RespiTrack': ■ Designed for respiratory patients, 'RespiTrack' provides information, resources, and tools. ■ Includes educational content,
  • 16. 6.Challenges and Considerations: • Regulatory Compliance: Stringent regulations govern promotional practices to ensure transparency, accuracy, and ethical engagements with healthcare professionals. • Balancing Promotion and Compliance: Successfully branding pharmaceutical products requires navigating the regulatory landscape while adhering to innovative and targeted strategies. • Positive Relationships: Companies must establish positive relationships with healthcare professionals and ensure effective communication with consumers. 7. Effectiveness: • Patient-centric marketing: ■ Builds trust. ■ Enhances brand loyalty. ■ Improves patient adherence.
  • 17. 1.Patent Issues and Generic Competition: • Patent Challenges: Innovator companies face challenges when patents expire, allowing generic manufacturers to produce affordable alternatives . • Generic Market: India's pharmaceutical market is characterized by a strong presence of generic drugs, which provide cost-effective options and challenge innovators to maintain their market share. • Impact on Sales: Patent expirations can lead to revenue erosion for innovator companies, necessitating strategic responses such as lifecycle management and innovative marketing strategies CHALLENGE AND OPPORTUNITIES
  • 18. • Public Health Risks: Counterfeit drugs pose serious health risks and undermine patient safety, often containing harmful or ineffective ingredients . • Regulatory Challenges: The vast and complex pharmaceutical market in India presents challenges in curbing counterfeit drug production and distribution . • Industry Reputation: The prevalence ofcounterfeit drugs can damage the reputation of the pharmaceutical industry and erode trust among stakeholders . • Economic Impact: Counterfeit drugs impact the financial sustainability of pharmaceutical companies by competing with genuine products. • Supply Chain Vulnerability: The intricate supply chain in India is vulnerable to infiltration by counterfeit drugs, highlighting the need for stringent control measures Counterfeit Drugs:
  • 20. ETHICAL CONSIDERATIONS 1.Clinical Trials and Research: • Informed Consent: Participants must be fully informed about the trial and consent to participate. • Participant Confidentiality: Protecting the privacy and personal information of participants. • Safety and Well-being: Ensuring the safety and well-being of trial subjects is paramount. • Ethical Review Boards: These boards oversee and approve research protocols to maintain the integrity of clinical
  • 21. 2.Marketing and Promotion: • Accurate Information: Companies must provide accurate and balanced information about their products. • Avoiding Misleading Claims: It's important to avoid making misleading claims about medications. • Transparency: Transparency in promotional materials and interactions with healthcare professionals is vital. 3.Access to Medicines: • Affordability: Companies must consider the affordability of medications, especially life-saving ones. • Balancing Profitability: There needs to be a balance between profitability and the societal impact of medications.
  • 22. 4.Compliance with Regulations: • Adherence to Laws: Companies must comply with laws and regulations governing drug development, manufacturing, marketing, and distribution. • Regulatory Bodies: In India, for example, the CDSCO sets regulations that companies must follow. 5.Corporate Social Responsibility (CSR): • Positive Contributions: Companies engage in CSR initiatives to contribute positively to communities. • Beyond Profit-making: Ethical corporate behavior involves commitments to social causes and public health challenges.
  • 24. Dynamic Landscape: • The pharmaceutical sector contributes significantly to the economy. • It operates within a complex regulatory environment that requires ethical vigilance. Market Dynamics: • The market is characterized by the presence of significant players. • Digital transformation and patient- centricity are key trends. • Counterfeit drugs and generic competition present ongoing challenges. CONCLUSION
  • 25. Strategic Balance: • There is a need to balance business objectives with ethical practices. • The industry must navigate between profitability and ethical responsibilities. Future Prospects: • Growth opportunities exist in the generic drug market and digital health solutions. • Emerging technologies are set to redefine sales and marketing strategies. • Innovation and regulatory agility will be pivotal for future success.
  • 26. THANK YOU PRESENTED BY SWAMI POOJA RAJKUMAR PRASHANTH KUMAR SONAL N PATEL MAYURI PRABHURAO PATIL YUVARAJ AMRUTH